1-烷基-3-(6-(2-甲氧基3-磺酰氨基-5-吡啶基-2-[1,2,4]三唑[1,5a]吡啶基)脲类的活性研究

来源 :2015年全国药物化学学术会议暨第五届中英药物化学学术会议 | 被引量 : 0次 | 上传用户:xhc042
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  N-(6-(2-甲氧基-3-(4-氟苯磺酰氨基)-5-吡啶基-2-[1,2,4]三唑[1,5-a]吡啶基乙酰胺(A)具有优异的抗肿瘤活性[1],但是其毒性较大。
其他文献
Labeling of human Ether-a-go-go-Related Gene(hERG)potassium channel with fluorescent probe has been becoming an essential tool in hERG-associated studies.[1,2] In this research,three small-molecule fl
The B-cell lymphoma(Bcl-2)family proteins are potential targets for cancer treatment.In our studies,a series of pyrrolidine derivatives were developed as potent myeloid cell leukemia sequence 1(Mcl-1)
Histone deacetylase(HDAC)has emerged as an attractive target for the development of antitumor agents during the past decade.[1] In our previous study,we designed and synthesized a novel series of N-hy
The long-term usage of HIV-1 non-nucleoside reverse transcriptase inhibitors(NNRTIs)usually leads to rapid emergence of mutant stains and severe side effects.
A series of novel 6-substituted diarylpyridine derivatives targeting the entrance channel of the NNRTI binding pocket(NNIBP)of HIV-1 RT was designed through a molecular hybridization strategy.
会议
Forty-two compounds(series 8,9 and 10)incorporated with diacylated piperazine have been synthesized and evaluated as novel Bcr-Abl inhibitors based on six-atom linker.
会议
化合物N-(2-氯-5-(2-乙酰氨基-6-苯并噻唑基)-3-吡啶基)-4-氟苯磺酰胺(A)具有优异的抗肿瘤活性[1],但是其毒性较大。
Phosphoinositide 3-kinase delta(PI3Kδ)is an attractive target for the treatment of hematological malignancies and autoimmune diseases.
会议